| 1996 | p53 protein expression in extrahepatic bile duct cancer
| YONSEI MEDICAL JOURNAL |
| 2008 | Paclitaxel augments cytotoxic effect of photodynamic therapy using verteporfin in gastric and bile duct cancer cells | PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES |
| 2009 | Pancreatic adenocarcinoma up-regulated factor (PAUF), a novel up-regulated secretory protein in pancreatic ductal adenocarcinoma | CANCER SCIENCE |
| 2018 | Pancreatic-cancer-cell-derived trefoil factor 2 impairs maturation and migration of human monocyte-derived dendritic cells in vitro
| ANIMAL CELLS AND SYSTEMS |
| 2012 | Pancreatoduodenectomy following neoadjuvant chemoradiation therapy in uncinate process pancreatic cancer. | PANCREAS |
| 2015 | Pathological Complete Remission of Pancreatic Cancer Following Neoadjuvant Chemoradiation Therapy; Not the End of Battles
| MEDICINE |
| 2004 | Patterns and relevant factors of tumor recurrence for extrahepatic bile duct carcinoma after radical resection | HEPATO-GASTROENTEROLOGY |
| 2003 | Percutaneous transhepatic choledochoscopic injection of ethanol with OK-432 mixture for palliation of malignant biliary obstruction | GASTROINTESTINAL ENDOSCOPY |
| 2009 | Perfusion CT: noninvasive surrogate marker for stratification of pancreatic cancer response to concurrent chemo- and radiation therapy | RADIOLOGY |
| 2021 | Peripheral natural killer cell activity is associated with poor clinical outcomes in pancreatic ductal adenocarcinoma | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2014 | Phase II clinical trial of ex vivo-expanded cytokine-induced killer cells therapy in advanced pancreatic cancer | CANCER IMMUNOLOGY IMMUNOTHERAPY |
| 2009 | Phase II study of 5-fluorouracil and paclitaxel in patients with gemcitabine-refractory pancreatic cancer | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
| 2006 | Phase II Study of Cisplatin Combined with Weekly Gemcitabine in the Treatment of Patients with Metastatic Pancreatic Carcinoma | PANCREATOLOGY |
| 2006 | Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2013 | Phase II Trial of Erlotinib Plus Gemcitabine Chemotherapy in Korean Patients with Advanced Pancreatic Cancer and Prognostic Factors for Chemotherapeutic Response
| GUT AND LIVER |
| 2009 | Phase II trial of S-1 and concurrent radiotherapy in patients with locally advanced pancreatic cancer | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
| 2023 | Phenotypic characteristics of circulating tumor cells and predictive impact for efficacy of chemotherapy in patients with pancreatic cancer: a prospective study
| FRONTIERS IN ONCOLOGY |
| 2010 | Placement of a fully covered self-expandable metal stent in a young patient with chronic pancreatitis
| WORLD JOURNAL OF GASTROINTESTINAL ENDOSCOPY |
| 2019 | Plasma Chromogranin A as a Prognostic Marker in Pancreatic Ductal Adenocarcinoma | PANCREAS |
| 2012 | Potential contribution of preoperative neoadjuvant concurrent chemoradiation therapy on margin-negative resection in borderline resectable pancreatic cancer | JOURNAL OF GASTROINTESTINAL SURGERY |
| 2020 | Preoperative prediction of futile surgery in patients with radiologically resectable or borderline resectable pancreatic adenocarcinoma | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2011 | Preoperative serum CA 19-9 level as a predictive factor for recurrence after curative resection in biliary tract cancer. | ANNALS OF SURGICAL ONCOLOGY |
| 2011 | Primary intestinal lymphangiectasia diagnosed by capsule endoscopy and double balloon enteroscopu
| WORLD JOURNAL OF GASTROINTESTINAL ENDOSCOPY |
| 2004 | Primary natural killer-cell lymphoma of the gastrointestinal tract | ENDOSCOPY |
| 2021 | Profiling of conditionally reprogrammed cell lines for in vitro chemotherapy response prediction of pancreatic cancer | EBIOMEDICINE |
| 2012 | Prognostic factors and characteristics of pancreatic neuroendocrine tumors: single center experience
| YONSEI MEDICAL JOURNAL |
| 2022 | Prognostic Factors in Patients Treated with Pembrolizumab as a Second-Line Treatment for Advanced Biliary Tract Cancer
| CANCERS |
| 2014 | Prognostic Significance of Volume-Based FDG PET/CT Parameters in Patients with Locally Advanced Pancreatic Cancer Treated with Chemoradiation Therapy
| YONSEI MEDICAL JOURNAL |
| 2016 | Prognostic Validity of the American Joint Committee on Cancer and the European Neuroendocrine Tumors Staging Classifications for Pancreatic Neuroendocrine Tumors: A Retrospective Nationwide Multicenter Study in South Korea | PANCREAS |
| 2013 | Prognostic value of 18F-fluorodeoxyglucose positron emission tomography in patients with resectable pancreatic cancer
| YONSEI MEDICAL JOURNAL |
| 2014 | Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative 18F-FDG PET/CT in Patients with Pancreatic Cancer | JOURNAL OF NUCLEAR MEDICINE |
| 2009 | Prognostic value of thymidine phosphorylase expression for pancreatic cancer. | HEPATO-GASTROENTEROLOGY |
| 2011 | Prospective phase II trial of gemcitabine in combination with irinotecan as first-line chemotherapy in patients with advanced biliary tract cancer. | CHEMOTHERAPY |
| 2016 | Prospective Study for Comparison of Endoscopic Ultrasound-Guided Tissue Acquisition Using 25- and 22-Gauge Core Biopsy Needles in Solid Pancreatic Masses
| PLOS ONE |
| 2011 | Proteomic analysis of pancreatic juice for the identification of biomarkers of pancreatic cancer | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
| 2020 | Radiographic portal or superior mesenteric vein invasion is an independent prognostic factor in non-metastatic pancreatic ductal adenocarcinoma: A missing block of clinical T staging? | PANCREATOLOGY |
| 2009 | Radiosensitization effect of STI-571 on pancreatic cancer cells in vitro | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS |
| 2013 | Radiotherapy Prolongs Biliary Metal Stent Patency in Malignant Pancreatobiliary Obstructions
| GUT AND LIVER |
| 2024 | Randomized Trial of Prophylactic Antibiotics for Endoscopic Retrograde Cholangiopancreatography in Patients With Biliary Obstruction
| AMERICAN JOURNAL OF GASTROENTEROLOGY |
| 2023 | Response | GASTROINTESTINAL ENDOSCOPY |
| 2022 | Response to Neoadjuvant Therapy and Prognosis in Patients with Resectable Pancreatic Cancer: A Propensity Score Matching Analysis
| GUT AND LIVER |
| 2009 | Reversal of diabetes in rats using GLP-1-expressing adult pancreatic duct-like precursor cells transformed from acinar to ductal cells | STEM CELLS AND DEVELOPMENT |
| 2016 | Risk Factors Associated with Loco-Regional Failure after Surgical Resection in Patients with Resectable Pancreatic Cancer.
| PLOS ONE |
| 2004 | Role of Exocrine Pancreatic Progenitor Cells in Pancreatic Carcinogenesis
| YONSEI MEDICAL JOURNAL |
| 2003 | Role of oxygen free radicals in patients with acute pancreatitis
| WORLD JOURNAL OF GASTROENTEROLOGY |
| 2012 | Safety of capsule endoscopy using human body communication in patients with cardiac devices | DIGESTIVE DISEASES AND SCIENCES |
| 2009 | Self-expandable metal stents for recurrent malignant obstruction after gastric surgery | HEPATO-GASTROENTEROLOGY |
| 2013 | Serum CA 19-9 and CEA Levels as a Prognostic Factor in Pancreatic Adenocarcinoma
| YONSEI MEDICAL JOURNAL |
| 2012 | Serum high mobility group box-1 is a powerful diagnostic and prognostic biomarker for pancreatic ductal adenocarcinoma. | CANCER SCIENCE |
| 2010 | Signet ring cell carcinoma of the extrahepatic bile duct
| GUT AND LIVER |
| 2020 | Single-center risk factor analysis for FOLFIRINOX associated febrile neutropenia in patients with pancreatic cancer | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
| 2019 | Skeletal Muscle Mass Predicts Poor Prognosis in Patients with Advanced Pancreatic Cancer Undergoing Second-Line FOLFIRINOX Chemotherapy | NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL |
| 2017 | Sorafenib inhibits 5-fluorouracil-resistant gastric cancer cell growth. | SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY |
| 2016 | Statin Use and Its Impact on Survival in Pancreatic Cancer Patients Cancer Patients
| MEDICINE |
| 2004 | Strategies to Improve Dendritic Cell-based Immunotherapy against Cancer
| YONSEI MEDICAL JOURNAL |
| 2006 | Suppression of human selenium-binding protein 1 is a late event in colorectal carcinogenesis and is associated with poor survival | PROTEOMICS |
| 2017 | Suppression of pancreatic adenocarcinoma upregulated factor (PAUF) increases the sensitivity of pancreatic cancer to gemcitabine and 5FU; and inhibits the formation of pancreatic cancer stem like cells
| ONCOTARGET |
| 2006 | Synthesis and characterization of mesoporous Fe/SiO2 for magnetic drug targeting | JOURNAL OF MATERIALS CHEMISTRY |
| 2006 | The clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the differential diagnosis, staging, and response evaluation after concurrent chemoradiotherapy for pancreatic cancer | JOURNAL OF CLINICAL GASTROENTEROLOGY |
| 2006 | The clinicopathologic significance of the expression of vascular endothelial growth factor-C in intrahepatic cholangiocarcinoma | AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS |
